ArticleInfectious diseases and therapy2025

Cost-Effectiveness Analysis of Expanding Influenza Vaccination to Adults Aged 50 and Over in France.

Guillaume Béraud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.